Hydrogels are promising for biomedical applications due to their tunable properties and extracellular matrix (ECM)-mimicking capabilities, but available chemistries limit customization potential. We present a modular bioconjugation system using polyphenol radical crosslinking, where gallic acid (GA)-modified glycosaminoglycans rapidly crosslink with diverse biomolecules under blue light and riboflavin. This method enables the creation of customizable, cell-compatible matrices. We validate conjugation chemistry using 1 H NMR, size-exclusion chromatography, and gel electrophoresis. As proof-of-concept, we have created injectable hydrogels from GA-modified hyaluronic acid (HA-GA) crosslinked with various proteins. Mechanical properties are tunable via riboflavin concentration and light exposure. HCT116 colon cancer cells form spheroids in HA-GA-BSA, while other protein-containing hydrogels support dispersed growth, indicating enhanced cell adhesion. HA-GA hydrogels upregulate stemness markers compared to 2D culture, while protein incorporation reduces this effect. Matrix-activated Wnt signaling confirms functional biomolecule integration using HA-GA-Wnt3A matrices. This strategy enables tailored ECM design for tissue engineering and 3D cell culture.
No takes yet. Share an insight, caveat, or question.
Evans et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: